Genprex, Inc. (GNPX): Earnings growth forecast for next year
Genprex, Inc. is implementing AI-driven robotics for gene delivery, synchronizing this with seamless management of international oncology CROs. On GURU.Markets, the projected net income per share growth rate reflects expectation dynamics, where the indicator level stands at 0.00. The company's strategy is based on delegating formula development and production to third-party partners, maintaining its status as a pure-play research center.
genprex.com (GNPX) - metric breakdowns and financial figures
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- book capitalization indicators:
- debt level and financial liquidity data:
- earnings and valuation multiples information:
GNPX - Final Profit|Projected Future Earnings Genprex, Inc.|GNPX - Business Payback Period|Future Price to Earnings Genprex, Inc.|GNPX - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Genprex|GNPX - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Genprex|GNPX - Net earnings per share for the last four quarters|Quarterly EPS earnings growth genprex.com|GNPX - Net earnings per share change in current year|Net earnings per share growth forecast for next year Genprex, Inc.
- total revenue and sales volume data:
Fundamental company valuation:Genprex, Inc, GNPX
This indicator measures the expected earnings per share (EPS) dynamics, determining whether a period of consolidation serves as a capital accumulation phase or a sign of declining profitability. The metric acts as a portfolio stress-testing tool, identifying hidden risks of profit shortfalls over the long term. By analyzing the consensus forecast for forward EPS growth rates, investors can see how the valuation of Genprex, Inc. (GNPX) depends on the validation results of the Reqorsa platform and the pace of the R&D pipeline.
Competitors of Genprex, Inc.
ONC (BeiGene Corp) - Earnings growth forecast for next year|Expected net earnings per share growth next year Halozyme Corp HALO|Earnings growth forecast for next year RVMD|ascentage.com (AAPG) - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year CGON (CG Oncology)|UroGen Pharma Ltd (URGN) - Expected net earnings per share growth next year|BCAX - Net earnings per share growth forecast for next year|PSNL (Personalis Genomics) - Projected earnings per share growth rate for next year|Erasca, Inc. (ERAS) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year DCTH (delcath.com)|Net earnings per share growth forecast for next year Y-mAbs Therapeutics, Inc.|AURA: Expected earnings per share trend next year|Earnings growth forecast for next year CADL|ARAY - Expected net earnings per share growth next year|SELLAS Life Sciences Group - Expected earnings per share growth for next year|ACTU: Projected earnings per share growth rate for next year|CTOR: Expected earnings per share growth for next year|Expected earnings per share trend next year HURA (TuHURA Biosciences, Inc.)|TARA: Earnings growth forecast for next year|FATE - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Aadi Bioscience, Inc.|Projected earnings per share growth rate for next year TCRX (TScan)|Earnings growth forecast for next year CSBR|Expected earnings per share growth for next year xbiotech.com XBIT|CEL-SCI - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year OS Therapies, Inc. (OSTX)|Radiopharm Theranostics Limited - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Artiva Biotherapeutics, Inc. (ARTV)|adlainortye.com (ANL) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year VERU|Net earnings per share growth forecast for next year Tempest Tx|Xilio - Net earnings per share change forecast for next year|Expected earnings per share growth for next year RENB (Renovaro Inc.)|muraloncology.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year KAPA (Kairos Pharma)|OKUR - Expected earnings per share growth for next year|CytoMed - Earnings growth forecast for next year|CRIS - Earnings growth forecast for next year|apollomicsinc.com (APLM) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year THAR|ADVB (Advanced Biomed Inc.) - Earnings growth forecast for next year|Expected earnings per share growth for next year Calidi Bio (CLDI)|Earnings growth forecast for next year SBFM|XBIO - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Salarius Pharmaceuticals SLRX|Expected earnings per share trend next year PPBT|AONC: Expected earnings per share growth for next year|Expected earnings per share trend next year BGNE (BeiGene Ltd.)|CKPT: Earnings growth forecast for next year|Expected earnings per share growth for next year elevationoncology.com|Expected earnings per share growth for next year ICAD|Earnings growth forecast for next year Ikena|Net earnings per share growth forecast for next year Notable Labs (NTBL)|VIRX (viracta.com) - Expected earnings per share trend next year|Earnings growth forecast for next year MOR (MorphoSys Corp)|NAYA Biosciences Corp (NAYA) - Expected net earnings per share growth next year|Ascentage Pharma Group - Earnings growth forecast for next year
